Covid-19: Cadila immunomodulator for treatment in 2 months
AHMEDABAD: The Ahmedabad based Cadila Pharmaceuticals, in partnership with India’s premier research organization Council of Scientific and Industrial Research (CSIR) seems to be on the path of a major breakthrough.…
Health Ministry to conduct 1 lakh tests per day with Indian kits by May
NEW DELHI: India will produce its rapid antibody testing kits independently and RTPCR diagnostic kits by May and the country would try to make possible to meet the target of…
COVID-19: Strides Pharma develops antiviral tablets
New Delhi: Strides Phaarma has developed and commercialised Favipiravir antiviral tablets and stressed that the drug has gives positive outcomes in COVID-19 treatment globally. “The drug has demonstrated positive outcomes,…
Compulsory Payment of Wages during Lockdown. Pharma Perspective. Who are covered?
India, like many other countries of the world, is fighting the novel coronavirus by maintaining social distancing and restricting the business activities to bare minimum. The country has been under…
AYUSH Ministry suggests to bring Indian traditional medicines under Drug & Cosmetics Act 1940
A notification has been issued based on consultation with CDSCO informing that scientists, researchers, clinicians can conduct research on novel coronavirus through Ayurveda, Homeopathy, by following necessary guidelines. The AYUSH…
‘Ayur Raksha’ clinics started by Kerala Government
Ayurveda bodies at the state, regional and district levels for a COVID-19 prevention programme has started by Kerala Government and ‘Ayur Raksha‘ clinics at government hospitals at district and taluk…
Health Ministry: Indigenous testing kits of Covid-19 to be available from May
Dr Harsh Vardhan, Union Health Minister on Tuesday said that the country will be able to produce indigenous coronavirus-testing kits by May. “We will be able to produce RT-PCR and…
Covid-19: Nursing homes to face action by BMC
In a statement issued by BMC that it will issue notices to around 25% of the total 1,496 nursing homes in the city asking them why the nursing homes should…
Delhi High Court imposed Rs 400 cap on rapid testing kits from China
NEW DELHI: Delhi high court capped the price of 4.5 lakh Covid-19 rapid testing kits that are likely to be delievered by China at Rs 400 each. Justice Waziri’s order…
ICMR: Stop using rapid test kits of 2 chinese firms
The ICMR released a statement that, “Several States have procured rapid antibody test kits and on their demand, ICMR has also provided these kits with clear instructions that they are…

Diabetic drug metformin found to act on brain
Hetero debuts semaglutide generic in emerging markets
LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial
Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority
Stem cell therapy for autism illegal: NMC advisory
India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework
Delhi HC Asks Dr Reddy’s To Halt Olymviq Sales; Flags Similarity With Novo Nordisk’s Ozempic
NPPA allows 0.64% hike in MRP of essential drugs in line with WPI rise
Govt Outlines AYUSH Heavy Metal Monitoring Steps In Rajya Sabha
Regulation Of Hair Transplant And Cosmetic Clinics Under The Purview Of States, No Plans To Create A Central Database Or Registry: Govt In RS